BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26181363)

  • 1. The class II transactivator (CIITA) is regulated by post-translational modification cross-talk between ERK1/2 phosphorylation, mono-ubiquitination and Lys63 ubiquitination.
    Morgan JE; Shanderson RL; Boyd NH; Cacan E; Greer SF
    Biosci Rep; 2015 Jun; 35(4):. PubMed ID: 26181363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogen-activated protein kinase ERK1/2 regulates the class II transactivator.
    Voong LN; Slater AR; Kratovac S; Cressman DE
    J Biol Chem; 2008 Apr; 283(14):9031-9. PubMed ID: 18245089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.
    Bhat KP; Truax AD; Greer SF
    J Biol Chem; 2010 Aug; 285(34):25893-903. PubMed ID: 20538595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.
    Bhat KP; Truax AD; Brooks JK; Greer SF
    Immunol Cell Biol; 2010; 88(8):807-16. PubMed ID: 20351748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulling a Ligase out of a "HAT": pCAF Mediates Ubiquitination of the Class II Transactivator.
    Morgan JE; Greer SF
    Int J Cell Biol; 2017; 2017():8093813. PubMed ID: 28286521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis.
    Waldburger JM; Palmer G; Seemayer C; Lamacchia C; Finckh A; Christofilopoulos P; Baeten D; Reith W; Gabay C
    Arthritis Rheum; 2011 Nov; 63(11):3354-63. PubMed ID: 21739421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a nuclear export sequence in the MHC CIITA.
    Chiu E; Gold T; Fettig V; LeVasseur MT; Cressman DE
    J Immunol; 2015 Jun; 194(12):6102-11. PubMed ID: 25948812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine signaling inhibits CIITA-mediated MHC class II transactivation in lung fibroblast cells.
    Fang M; Xia J; Wu X; Kong H; Wang H; Xie W; Xu Y
    Eur J Immunol; 2013 Aug; 43(8):2162-73. PubMed ID: 23681904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MHC II genes.
    Drozina G; Kohoutek J; Jabrane-Ferrat N; Peterlin BM
    Curr Top Microbiol Immunol; 2005; 290():147-70. PubMed ID: 16480042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters.
    Tosi G; Jabrane-Ferrat N; Peterlin BM
    EMBO J; 2002 Oct; 21(20):5467-76. PubMed ID: 12374747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
    Forlani G; Abdallah R; Accolla RS; Tosi G
    J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
    Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V
    PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide CIITA-binding profile identifies sequence preferences that dictate function versus recruitment.
    Scharer CD; Choi NM; Barwick BG; Majumder P; Lohsen S; Boss JM
    Nucleic Acids Res; 2015 Mar; 43(6):3128-42. PubMed ID: 25753668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.
    Zhao M; Flynt FL; Hong M; Chen H; Gilbert CA; Briley NT; Bolick SC; Wright KL; Piskurich JF
    Mol Immunol; 2007 Apr; 44(11):2923-32. PubMed ID: 17300840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of CIITA transcriptional function by ubiquitin.
    Greer SF; Zika E; Conti B; Zhu XS; Ting JP
    Nat Immunol; 2003 Nov; 4(11):1074-82. PubMed ID: 14528304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells.
    Kong X; Fang M; Li P; Fang F; Xu Y
    J Mol Cell Cardiol; 2009 Mar; 46(3):292-9. PubMed ID: 19041327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
    Rohn W; Tang LP; Dong Y; Benveniste EN
    J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of class II transactivator leucine-rich repeats for dominant-negative function and nucleo-cytoplasmic transport.
    Camacho-Carvajal MM; Klingler S; Schnappauf F; Hake SB; Steimle V
    Int Immunol; 2004 Jan; 16(1):65-75. PubMed ID: 14688062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of MHC class II expression through inhibition of CIITA transcription by lytic transactivator Zta during Epstein-Barr virus reactivation.
    Li D; Qian L; Chen C; Shi M; Yu M; Hu M; Song L; Shen B; Guo N
    J Immunol; 2009 Feb; 182(4):1799-809. PubMed ID: 19201831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.